Zeit Aktuelle Nachrichten 13.02. Sedana Medical AB: Sedana Medical AB's Year-end report 2024 Primary endpoint met in both US trials and positive ex-US EBITDA excl. one-offs in Q4 Fourth quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback